New Trump tariffs on pharmaceuticals could double the cost of common prescription drugs, raising prices for medications like Entresto and Keytruda for patients.

This essay is a part of The Right Way Forward, Restoring America’s new think tank debate series in which leading conservative ...

President Trump’s “most favored nation” drugmaker deals could save the economy $529 billion over the next decade, a new White ...

Few of the details about the deals have been made public, making it hard to independently verify the projected savings.

Since his second term started, President Trump has introduced a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry.

President Trump’s new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply chain, with experts calling for more clarity and details into the White ...

President Trump has unveiled steep new tariffs on pharmaceutical drugs, furniture, kitchen cabinets, bathroom vanities and heavy trucks – threatening to raise prices as Americans are already dealing ...

Regeneron agreed to reduce prices for its current and future medications sold to Medicaid, and to lower the price of its cholesterol drug Praluent to $225 for Americans through the TrumpRx.gov website ...

The first week of October 2025 marked a significant shift in U.S. drug pricing policy as the Trump administration unveiled a series of sweeping actions to deliver on his promise to lower drug prices.

President Donald Trump has signed an executive order that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies that don’t reach deals with his ...

In today's Pharmaceutical Executive Daily, GSK enters an exclusive collaboration with Sino Biopharmaceutical's CTTQ ...